García-Merino A - Search Results

1

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.

Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J. Cabranes A, et al. Neurobiol Dis. 2005 Nov;20(2):207-17. doi: 10.1016/j.nbd.2005.03.002. Neurobiol Dis. 2005. PMID: 16242629

2

Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.

Berrendero F, Sánchez A, Cabranes A, Puerta C, Ramos JA, García-Merino A, Fernández-Ruiz J. Berrendero F, et al. Synapse. 2001 Sep 1;41(3):195-202. doi: 10.1002/syn.1075. Synapse. 2001. PMID: 11391780

3

Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis.

Sánchez AJ, Puerta C, Ballester S, González P, Arriaga A, García-Merino A. Sánchez AJ, et al. J Neuroimmunol. 2005 Nov;168(1-2):13-20. doi: 10.1016/j.jneuroim.2005.03.024. Epub 2005 Sep 22. J Neuroimmunol. 2005. PMID: 16182379

4

R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.

Sánchez AJ, González-Pérez P, Galve-Roperh I, García-Merino A. Sánchez AJ, et al. Biochem Pharmacol. 2006 Dec 15;72(12):1697-706. doi: 10.1016/j.bcp.2006.08.018. Epub 2006 Aug 26. Biochem Pharmacol. 2006. PMID: 17007821

5

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.

Ramil E, Sánchez AJ, González-Pérez P, Rodríguez-Antigüedad A, Gómez-Lozano N, Ortiz P, Arroyo R, De las Heras V, Vilches C, García-Merino A. Ramil E, et al. Mult Scler. 2010 Feb;16(2):139-46. doi: 10.1177/1352458509355071. Epub 2009 Dec 9. Mult Scler. 2010. PMID: 20007426

6

Neuroprotective agents: cannabinoids.

Sánchez AJ, García-Merino A. Sánchez AJ, et al. Clin Immunol. 2012 Jan;142(1):57-67. doi: 10.1016/j.clim.2011.02.010. Epub 2011 Mar 21. Clin Immunol. 2012. PMID: 21420365 Review.

7

Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients.

Sánchez López AJ, Román-Vega L, Ramil Tojeiro E, Giuffrida A, García-Merino A. Sánchez López AJ, et al. Clin Exp Immunol. 2015 Jan;179(1):119-27. doi: 10.1111/cei.12443. Clin Exp Immunol. 2015. PMID: 25169051 Free PMC article.

8

Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.

Moreno Torres I, Sanchez AJ, Garcia-Merino A. Moreno Torres I, et al. Expert Rev Neurother. 2014 Nov;14(11):1243-50. doi: 10.1586/14737175.2014.971758. Expert Rev Neurother. 2014. PMID: 25331416 Review.

9

Platelet-activating factor antagonists do not protect against the development of experimental autoimmune encephalomyelitis.

Vela L, García Merino A, Fernández-Gallardo S, Sánchez Crespo M, López Lozano JJ, Saus C. Vela L, et al. J Neuroimmunol. 1991 Jul;33(1):81-6. doi: 10.1016/0165-5728(91)90037-8. J Neuroimmunol. 1991. PMID: 2056071

10

Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase.

Martínez I, Puerta C, Redondo C, García-Merino A. Martínez I, et al. J Neurol Sci. 1999 Mar 15;164(1):13-23. doi: 10.1016/s0022-510x(99)00050-7. J Neurol Sci. 1999. PMID: 10385042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters